| RS1555221197 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1555221202 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555221275 |
SMARCC2
|
Health Risk |
Pathogenic |
SMARCC2-related disorder, SMARCC2-related BAFopathy |
| RS1555221512 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1555221894 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555221903 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555221914 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555221919 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555222073 |
CEP290
|
Health Risk |
Pathogenic |
Leber congenital amaurosis, Leber congenital amaurosis |
| RS1555222243 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555222342 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Intrauterine growth retardation, metaphyseal dysplasia |
| RS1555222376 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555222457 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555222526 |
POLE
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555222548 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555222567 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1555222696 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1555222708 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555222899 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555222907 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555222948 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555222973 |
CREB3L1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 16, Osteogenesis imperfecta |
| RS1555222974 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1555223073 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1555223081 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555223097 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555223259 |
TBX5
|
Health Risk |
Pathogenic |
Atrial septal defect, ostium secundum type |
| RS1555223294 |
TBX5
|
Health Risk |
Likely pathogenic |
Congenital heart disease (variable), Congenital heart disease (variable) |
| RS1555223390 |
OAS1
|
Health Risk |
Likely pathogenic |
Pulmonary alveolar proteinosis with hypogammaglobulinemia, Pulmonary alveolar proteinosis with hypogammaglobulinemia |
| RS1555223595 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1555223925 |
FGF9
|
Health Risk |
Pathogenic |
Multiple synostoses syndrome 3, Multiple synostoses syndrome 3 |
| RS1555223943 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555223949 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1555224105 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555224111 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1555224124 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555224126 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555224371 |
SCN8A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555224772 |
FGD4
|
Health Risk |
Likely pathogenic |
— |
| RS1555225149 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1555225184 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS1555225201 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, POLE-related disorder |
| RS1555225288 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555225303 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555225319 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555225344 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Holt-Oram syndrome |
| RS1555225472 |
MED13L
|
Health Risk |
Pathogenic |
— |
| RS1555225498 |
SCN8A
|
Health Risk |
Likely pathogenic |
Autosomal recessive inheritance, Global developmental delay |
| RS1555225505 |
SCN8A
|
Health Risk |
Likely pathogenic |
Cognitive impairment with or without cerebellar ataxia, Cognitive impairment with or without cerebellar ataxia |
| RS1555225532 |
SCN8A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1555225566 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1555225636 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555225782 |
SCN8A
|
Health Risk |
Pathogenic |
Cognitive impairment with or without cerebellar ataxia, Cognitive impairment with or without cerebellar ataxia |
| RS1555225794 |
SCN8A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS1555225831 |
SCN8A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1555225835 |
SCN8A
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia, Intellectual disability |
| RS1555225958 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1555225989 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS1555226005 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS1555226051 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555226055 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, POLE-related disorder |
| RS1555226059 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555226065 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555226066 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1555226079 |
SCN8A
|
Health Risk |
Pathogenic |
— |
| RS1555226081 |
SCN8A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555226280 |
SCN8A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555226301 |
TBX5
|
Health Risk |
Likely pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS1555226305 |
TBX5
|
Health Risk |
Pathogenic |
— |
| RS1555226315 |
TBX5
|
Health Risk |
Pathogenic |
Atrial septal defect 1, Holt-Oram syndrome |
| RS1555226322 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS1555226371 |
SCN8A
|
Health Risk |
Pathogenic |
— |
| RS1555226375 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1555226395 |
SYT1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555226411 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555226412 |
TBX5
|
Health Risk |
Pathogenic |
— |
| RS1555226417 |
CPT1A
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase 1A deficiency, Carnitine palmitoyl transferase 1A deficiency |
| RS1555226418 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555226420 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS1555226430 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555226575 |
TBX5
|
Health Risk |
Likely pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS1555226581 |
TBX5
|
Health Risk |
Pathogenic/Likely pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS1555226584 |
TBX5
|
Health Risk |
Likely pathogenic |
— |
| RS1555226588 |
TBX5
|
Health Risk |
Pathogenic |
— |
| RS1555226823 |
SCN8A
|
Health Risk |
Pathogenic |
COGNITIVE IMPAIRMENT WITHOUT CEREBELLAR ATAXIA, Early-infantile DEE |
| RS1555226860 |
SCN8A
|
Health Risk |
Likely pathogenic |
Cognitive impairment with or without cerebellar ataxia, Cognitive impairment with or without cerebellar ataxia |
| RS1555227097 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555227130 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555227234 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1555227419 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555227607 |
CPT1A
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase 1A deficiency, Carnitine palmitoyl transferase 1A deficiency |
| RS1555228198 |
RXYLT1
|
Health Risk |
Likely pathogenic |
— |
| RS1555228250 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555228293 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1555228303 |
SCN8A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Developmental and epileptic encephalopathy |
| RS1555228304 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1555228329 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 13 |
| RS1555228350 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Cognitive impairment with or without cerebellar ataxia |
| RS1555228358 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
POLE-related disorder, POLE-related disorder |
| RS1555228470 |
CPT1A
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase 1A deficiency, Carnitine palmitoyl transferase 1A deficiency |